Translate this page into:
Erratum: Methylprednisolone pulse therapy for leprosy neuritis: A retrospective study with sensory testing and peripheral nerve ultrasonography correlation
Read CORRECTED-ARTICLE associated with this - 10.25259/IJDVL_1280_20
In the article entitled “Methylprednisolone pulse therapy for leprosy neuritis: A retrospective study with sensory testing and peripheral nerve ultrasonography correlation” which was published in the Indian Journal of Dermatology, Venereology and Leprology on page 114-6, Issue 1, Volume 88, January-March 2022,1 the following paragraph was missing under the section “Financial support and sponsorship.”
The “Financial support and sponsorship” statement is as under.
-
Dr. Lugao received research funding from FUNADERSP - Brazilian Society of Dermatology (Grant number: 62/2017; https://www.sbd-sp.org.br) and from FIOTEC - Fiocruz (Grant number: PRES-009-FIO-20; https://www.fiotec.fiocruz.br/en). Dr. Frade received research funding from Ministerio da Saude/Fundau00e7u00e3o de Apoio ao Ensino, Pesquisa e Assistencia do Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto da Universidade de Sao Paulo (MS/FAEPA- FMRP- USP). Grant numbers: 749145/2010 and 767202/2011; www.faepa.br.
Reference
- Methylprednisolone pulse therapy for leprosy neuritis: A retrospective study with sensory testing and peripheral nerve ultrasonography correlation. Indian J Dermatol Venereol Leprol. 2022;88:114-6.
- [CrossRef] [PubMed] [Google Scholar]